Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Jounce Therapeutics Inc (NQ: JNCE )

7.270 USD -0.190 (-2.55%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 598,068
Open 7.400
Bid (Size) 7.010 (10)
Ask (Size) 7.960 (26)
Prev. Close 7.460
Today's Range 7.255 - 7.570
52wk Range 4.430 - 14.84
Shares Outstanding 51,208,357
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Jounce Therapeutics to Host Virtual R&D Day on June 23, 2021
From GlobeNewswire News Releases
Jounce Therapeutics Achieves First Milestone in Exclusive License Agreement with Gilead Sciences and FDA Clearance of Investigational New Drug Application for Anti-CCR8 Antibody
From GlobeNewswire News Releases

Performance

YTD
+7.39%
+7.39%
1 Month
-8.78%
-8.78%
3 Month
-38.96%
-38.96%
6 Month
+9.16%
+9.16%
1 Year
+15.03%
+15.03%

More News

Read More
Jounce Therapeutics to Participate in Fireside Chat at the Raymond James Human Health Innovation Conference
From GlobeNewswire News Releases
Jounce Therapeutics Presents Trial in Progress Posters on the INNATE and SELECT Clinical Trials at the 2021 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting
From GlobeNewswire News Releases
Jounce Therapeutics Reports First Quarter 2021 Financial Results
From GlobeNewswire News Releases
First Week of August 20th Options Trading For Jounce Therapeutics (JNCE)
Tags Stocks
From Market News Video
Jounce Therapeutics to Present Trial in Progress Posters on the Phase 1 INNATE and the Phase 2 SELECT Clinical Trials at the 2021 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting
From GlobeNewswire News Releases
How The Parts Add Up: IEIH Targets $40
Tags ETFs
From ETF Channel
Jounce Therapeutics to Announce First Quarter 2021 Financial Results and Host Conference Call on Tuesday, May 4, 2021
From GlobeNewswire News Releases
Notable Tuesday Option Activity: JNCE, GSHD, RNST
Tags Stocks
From Market News Video
12 Health Care Stocks Moving In Tuesday's Intraday Session
Tags FUSN JNCE CLSD
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]